n.a. (BRLI)

34.61
0.34 0.97
NASDAQ
Prev Close 34.95
Open 34.74
Day Low/High 34.03 / 34.96
52 Wk Low/High /
Volume 423.74K
Exchange NASDAQ
Div & Yield N.A. (N.A)
BioReference Laboratories, Inc. Announces Earnings Date For Third Quarter, Fiscal Year 2011

BioReference Laboratories, Inc. Announces Earnings Date For Third Quarter, Fiscal Year 2011

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the third quarter, fiscal year 2011 before the open of market trading on Thursday, August 25th, 2011.

BioReference Laboratories, Inc To Speak At William Blair & Company’s 31st Annual Growth Stock Conference

BioReference Laboratories, Inc To Speak At William Blair & Company’s 31st Annual Growth Stock Conference

Bio-Reference Laboratories, Inc (NASDAQ - “BRLI”) announced today that Marc D.

BioReference Laboratories, Inc. To Speak At The 2011 Jefferies Global Healthcare Conference

BioReference Laboratories, Inc. To Speak At The 2011 Jefferies Global Healthcare Conference

BioReference Laboratories, Inc. (NASDAQ - “BRLI”) announced today that Marc D.

Bio-Reference Reaches New 52-Week High (BRLI)

Bio-Reference Reaches New 52-Week High (BRLI)

Bio-Reference Labs (Nasdaq:BRLI) hit a new 52-week high Thursday as it is currently trading at $25.62, above its previous 52-week high of $25.43 with 41,899 shares traded as of 9:36 a.m. ET. Average volume has been 176,000 shares over the past 30 days.

Bio-Reference Laboratories, Inc. Reports Record Quarterly Success

Bio-Reference Laboratories, Inc. Reports Record Quarterly Success

Please replace the release with the following corrected version due to multiple revisions to the Statement of Operations table (Six Months Ended, April 30) The corrected release reads: ...

Heavily Shorted Stocks That Could Pop on Earnings

Heavily Shorted Stocks That Could Pop on Earnings

These heavily shorted stocks could get squeezed higher if they report positive earnings this week.

BioReference Laboratories, Inc. Announces Earnings Date For Second Quarter For Fiscal Year 2011

BioReference Laboratories, Inc. Announces Earnings Date For Second Quarter For Fiscal Year 2011

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the second quarter of fiscal 2011 before the open of market trading on Thursday, May 26, 2011.

BioReference Laboratories, Inc. To Speak At The Bank Of America Merrill Lynch Health Care Conference

BioReference Laboratories, Inc. To Speak At The Bank Of America Merrill Lynch Health Care Conference

BioReference Laboratories, Inc. (NASDAQ - “BRLI”) announced today that Marc D.

Bio-Reference Stock Hits New 52-Week High (BRLI)

Bio-Reference Stock Hits New 52-Week High (BRLI)

Bio-Reference Labs (Nasdaq:BRLI) hit a new 52-week high Thursday as it is currently trading at $24.72, above its previous 52-week high of $24.66 with 131,573 shares traded as of four p.m. ET. Average volume has been 175,300 shares over the past 30 days.

BioReference Laboratories, Inc. Reports 23% Revenue, 20% Patient Count Increase In Solid Quarterly Results

BioReference Laboratories, Inc. Reports 23% Revenue, 20% Patient Count Increase In Solid Quarterly Results

BioReference Laboratories, Inc. (NASDAQ: BRLI) (Numbers in Thousands Except Per Share Data or where otherwise noted) released its first quarter, fiscal year 2011 earnings today for the three months ending January 31.

Guru-based Investing, Munis and Madison, Oil and the Economy

Guru-based Investing, Munis and Madison, Oil and the Economy

NEW YORK (TheStreet) -- Guests include Richard Ciccarone, managing director at McDonnell Investment Management, Michael Yoshikami, chief investment officer at YCMNET Advisors and John Reese, co-founder of Validea.com

BioReference Laboratories, Inc. Announces Earnings Date For First Quarter For Fiscal Year 2011

BioReference Laboratories, Inc. Announces Earnings Date For First Quarter For Fiscal Year 2011

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the first quarter of fiscal 2011 before the open of market trading on Thursday, March 3, 2011.

Emerald Holds Annual Groundhog Day Investment Forum

Emerald Holds Annual Groundhog Day Investment Forum

Emerald Asset Management will hold it’s Eighteenth Annual Emerald Groundhog Day Investment Forum on Wednesday, February 2, 2011 at the Radisson Plaza-Warwick Hotel in Philadelphia .

Bio-Reference Laboratories, Inc. Announces Record Revenues And Earnings For Fourth Quarter And Fiscal Year

Bio-Reference Laboratories, Inc. Announces Record Revenues And Earnings For Fourth Quarter And Fiscal Year

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, Numbers are in Thousands) announced best ever Company quarterly and annual fiscal year results.

BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2010

BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2010

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the fourth quarter and year end of fiscal 2010 before the open of market trading on Thursday, December 16, 2010.

Bio-Reference Laboratories, Inc. Announces Massachusetts General Hospital Agreement For Collaboration

Bio-Reference Laboratories, Inc. Announces Massachusetts General Hospital Agreement For Collaboration

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced that the Company and Massachusetts General Hospital (MGH) have entered into a definitive agreement to collaborate in the development of clinical diagnostic...

BioReference Laboratories, Inc. To Speak At The Lazard Capital Markets 7th Annual Healthcare Conference

BioReference Laboratories, Inc. To Speak At The Lazard Capital Markets 7th Annual Healthcare Conference

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today that Marc D.

BioReference Laboratories, Inc. To Speak At The UBS Global Life Sciences Conference

BioReference Laboratories, Inc. (NASDAQ:BRLI) announced today that Marc D.

Bio-Reference Laboratories, Inc. Announces 25% Revenue Growth, 17% Patient Growth, Record Income

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $121,719, the best ever ...

BioReference Laboratories, Inc. Announces Earnings Date For Third Quarter For Fiscal Year 2010

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the third quarter of fiscal 2010 before the open of market trading on Thursday, August 26, 2010.

Bio-Reference Laboratories, Inc. Reports Record Quarterly Revenues

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Numbers in Thousands Except Per Share Data or where otherwise noted) released its second quarter, fiscal year 2010 earnings today for the three months ending April 30.

Three Growth Stocks for a Bear Market

ITC Holdings, Bio-Reference Laboraties and American Science & Engineering are growth stocks in safe industries.

BioReference Laboratories, Inc. Announces Earnings Date For Second Quarter For Fiscal Year 2010

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the second quarter of fiscal 2010 before the open of market trading on Thursday, May 27, 2010.

A Biotech Stock Without the Risk

Bio-Reference Laboratories is no Dendreon, which is a good thing.

BioReference Laboratories, Inc. To Speak At The Bank Of America Merrill Lynch Health Care Conference

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today that Marc D.

BioReference Laboratories, Inc. Announces 2 For 1 Stock Split

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced the approval by its board of directors and the declaration today of a forward two for one split of its Common Stock entitling each holder of record of BRLI ...

BioReference Laboratories, Inc. Announces Earnings Date For First Quarter For Fiscal Year 2010

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the first quarter of fiscal 2010 before the open of market trading on Thursday, March 4, 2010.

Top 5 Fast-Growth Stocks With 'Buy' Ratings

Healthcare Services Group, Lincoln Educational Services, Bio-Reference Laboratories, DeVry and Strayer are rated 'buy.'

The Top Five Mid-Cap Stocks

Bio-Reference Laboratories, Strayer, Maximus, DeVry and Church & Dwight receive top-marks from our stock-model.

Five Fast-Growth Companies Rated 'Buy'

Five Fast-Growth Companies Rated 'Buy'

Lincoln Educational Services, Strayer Education, Medco Health Solutions, Bio-Reference Laboratories and DeVry are rated 'buy.'